IN2014CN04470A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04470A IN2014CN04470A IN4470CHN2014A IN2014CN04470A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A IN 4470CHN2014 A IN4470CHN2014 A IN 4470CHN2014A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A
- Authority
- IN
- India
- Prior art keywords
- ketoreductase polypeptides
- preparation
- present disclosure
- making
- methods
- Prior art date
Links
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 108091033319 polynucleotide Chemical class 0.000 abstract 1
- 239000002157 polynucleotide Chemical class 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01184—Carbonyl reductase (NADPH) (1.1.1.184)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561665P | 2011-11-18 | 2011-11-18 | |
| PCT/US2012/065046 WO2013074650A1 (en) | 2011-11-18 | 2012-11-14 | Biocatalysts for the preparation of hydroxy substituted carbamates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04470A true IN2014CN04470A (enrdf_load_stackoverflow) | 2015-09-04 |
Family
ID=47295185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4470CHN2014 IN2014CN04470A (enrdf_load_stackoverflow) | 2011-11-18 | 2012-11-14 |
Country Status (8)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009029554A2 (en) | 2007-08-24 | 2009-03-05 | Codexis, Inc. | Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane |
| WO2013062878A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 angonists and intermediates |
| WO2013062881A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
| SG11201402401TA (en) | 2011-11-18 | 2014-06-27 | Codexis Inc | Biocatalysts for the preparation of hydroxy substituted carbamates |
| EP2970927A4 (en) * | 2013-03-15 | 2016-10-12 | Merck Sharp & Dohme | IMMOBILIZED KETOREDUCASTASES AND METHOD FOR THE PRODUCTION AND USE OF IMMOBILIZED KETOREDUCASTASES |
| SMT201900508T1 (it) | 2013-03-15 | 2019-11-13 | Merck Sharp & Dohme | Processo per preparare beta 3 agonisti e intermedi |
| ES2830725T3 (es) | 2015-02-10 | 2021-06-04 | Codexis Inc | Polipéptidos cetoreductasa para la síntesis de compuestos quirales |
| CN106011095B (zh) * | 2016-07-27 | 2021-02-26 | 苏州汉酶生物技术有限公司 | 工程化酮还原酶多肽及使用其制备依替米贝中间体的方法 |
| JP7682605B2 (ja) | 2017-06-06 | 2025-05-26 | ウロバント サイエンシズ ゲゼルシャフト ミット ベシュレンクター ハフトゥング | 過活動膀胱を治療するためのビベグロンの使用 |
| JP2022510084A (ja) | 2018-12-05 | 2022-01-26 | ウロバント サイエンシズ ゲーエムベーハー | 良性前立腺肥大症の男性の過活動膀胱症状を治療するためのビベグロンの使用 |
| CN109943543B (zh) * | 2019-03-28 | 2020-12-11 | 上海健康医学院 | 醇脱氢酶突变体及其制备方法和应用 |
| CN114410599B (zh) * | 2022-01-29 | 2023-08-18 | 浙江工业大学 | 羰基还原酶突变体及其制备瑞舒伐他汀手性中间体的应用 |
| CN116814569B (zh) * | 2023-05-30 | 2025-07-25 | 华东理工大学 | 一种催化活性提高的醇脱氢酶突变体、基因工程菌及其应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538867A (en) | 1988-09-13 | 1996-07-23 | Elf Aquitaine | Process for the electrochemical regeneration of pyridine cofactors |
| JP3155107B2 (ja) | 1993-01-12 | 2001-04-09 | ダイセル化学工業株式会社 | 光学活性４−ハロ−３−ヒドロキシ酪酸エステルの製造方法 |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| DE69535592T2 (de) | 1994-03-25 | 2008-06-12 | Isotechnika, Inc., Edmonton | Verbesserung der effektivität von arzneimitteln duren deuterierung |
| JPH08336393A (ja) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法 |
| FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| US5891685A (en) | 1996-06-03 | 1999-04-06 | Mitsubishi Chemical Corporation | Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid |
| US6342507B1 (en) | 1997-09-05 | 2002-01-29 | Isotechnika, Inc. | Deuterated rapamycin compounds, method and uses thereof |
| KR100585348B1 (ko) | 1997-10-08 | 2006-06-01 | 이소테크니카 인코포레이티드 | 중수소화된 시클로스포린 유사체 및 면역조절제로서 그의용도 |
| EP1036198B1 (en) | 1997-12-08 | 2012-09-26 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| US6495023B1 (en) | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
| DE19857302C2 (de) | 1998-12-14 | 2000-10-26 | Forschungszentrum Juelich Gmbh | Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester |
| JP4221100B2 (ja) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | 半導体装置 |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| DE60024615T2 (de) | 1999-03-11 | 2006-07-06 | Eastman Chemical Co., Kingsport | Phosphine Stabilisatoren für oxidoreduktase Enzyme |
| ATE291616T1 (de) | 1999-12-03 | 2005-04-15 | Kaneka Corp | Neue carbonyl-reduktase, gen davon und verfahren der anwendung derselben |
| WO2001075767A2 (en) | 2000-03-30 | 2001-10-11 | Maxygen, Inc. | In silico cross-over site selection |
| KR20030085012A (ko) | 2001-03-22 | 2003-11-01 | 브리스톨-마이어스스퀴브컴파니 | 치환된 아세토페논의 입체선택적 환원 |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| EP1660648B1 (en) | 2003-08-11 | 2013-10-09 | Codexis, Inc. | Improved glucose dehydrogenase polypeptides and related polynucleotides |
| JP2007502123A (ja) | 2003-08-11 | 2007-02-08 | コデクシス， インコーポレイテッド | 改善されたハロヒドリンデハロゲナーゼおよび関連するポリヌクレオチド |
| KR20060071397A (ko) | 2003-08-11 | 2006-06-26 | 코덱시스, 인코포레이티드 | 4-치환된 3-히드록시부티르산 유도체 및 이웃자리 시아노,히드록시 치환된 카르복실산 에스테르의 효소적 제조 방법 |
| WO2005017135A1 (en) | 2003-08-11 | 2005-02-24 | Codexis, Inc. | Improved ketoreductase polypeptides and related polynucleotides |
| JP4394647B2 (ja) | 2003-12-02 | 2010-01-06 | メルシャン株式会社 | 光学活性テトラヒドロチオフェン誘導体の製造方法、および、光学活性テトラヒドロチオフェン−３−オールの晶析方法 |
| US7705036B2 (en) | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
| US7393667B2 (en) | 2005-05-31 | 2008-07-01 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| EP2115130B1 (en) | 2007-02-08 | 2011-08-03 | Codexis, Inc. | Ketoreductases and uses thereof |
| WO2009008908A2 (en) | 2007-02-12 | 2009-01-15 | Codexis, Inc. | Structure-activity relationships |
| WO2009029554A2 (en) | 2007-08-24 | 2009-03-05 | Codexis, Inc. | Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane |
| CN101855342B (zh) | 2007-09-13 | 2013-07-10 | 科德克希思公司 | 用于还原苯乙酮的酮还原酶多肽 |
| CN101889081B (zh) | 2007-09-28 | 2014-06-18 | 科德克希思公司 | 酮还原酶多肽及其用途 |
| CN101883846A (zh) | 2007-10-01 | 2010-11-10 | 科德克希思公司 | 用于生成氮杂环丁酮的还原酶多肽 |
| PE20091825A1 (es) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
| US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
| WO2010025238A2 (en) | 2008-08-27 | 2010-03-04 | Codexis, Inc. | Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
| WO2010027710A2 (en) | 2008-08-27 | 2010-03-11 | Codexis, Inc. | Ketoreductase polypeptides and uses thereof |
| WO2010025287A2 (en) | 2008-08-27 | 2010-03-04 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
| CN102186972B (zh) | 2008-08-29 | 2014-08-20 | 科德克希思公司 | 用于立体选择性生产(4s)-3-[(5s)-5-(4-氟苯基)-5-羟基戊酰基]-4-苯基-1，3-噁唑烷-2-酮的酮还原酶多肽 |
| WO2011022548A2 (en) | 2009-08-19 | 2011-02-24 | Codexis, Inc. | Ketoreductase polypeptides for the preparation of phenylephrine |
| US9040262B2 (en) | 2010-05-04 | 2015-05-26 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
| SG11201402401TA (en) | 2011-11-18 | 2014-06-27 | Codexis Inc | Biocatalysts for the preparation of hydroxy substituted carbamates |
-
2012
- 2012-11-14 SG SG11201402401TA patent/SG11201402401TA/en unknown
- 2012-11-14 WO PCT/US2012/065046 patent/WO2013074650A1/en active Application Filing
- 2012-11-14 US US14/357,964 patent/US9139819B2/en active Active
- 2012-11-14 IN IN4470CHN2014 patent/IN2014CN04470A/en unknown
- 2012-11-14 CN CN201280067329.9A patent/CN104053771B/zh active Active
- 2012-11-14 EP EP12795954.2A patent/EP2780448B1/en active Active
- 2012-11-14 HU HUE12795954A patent/HUE046089T2/hu unknown
- 2012-11-14 CN CN201610911937.3A patent/CN106479990B/zh active Active
-
2014
- 2014-05-14 IL IL23262114A patent/IL232621B/en active IP Right Grant
-
2015
- 2015-08-13 US US14/825,688 patent/US9422531B2/en active Active
-
2016
- 2016-07-15 US US15/211,990 patent/US9803178B2/en active Active
-
2017
- 2017-09-21 US US15/711,119 patent/US10100287B2/en active Active
-
2018
- 2018-09-10 US US16/126,044 patent/US10253303B2/en active Active
-
2019
- 2019-02-25 US US16/284,235 patent/US10851351B2/en active Active
-
2020
- 2020-10-29 US US17/084,405 patent/US11713451B2/en active Active
-
2023
- 2023-06-12 US US18/333,393 patent/US12241093B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180371427A1 (en) | 2018-12-27 |
| US9803178B2 (en) | 2017-10-31 |
| US20210071151A1 (en) | 2021-03-11 |
| US12241093B2 (en) | 2025-03-04 |
| HUE046089T2 (hu) | 2020-01-28 |
| CN104053771A (zh) | 2014-09-17 |
| US20140322769A1 (en) | 2014-10-30 |
| EP2780448B1 (en) | 2019-09-11 |
| US20150344850A1 (en) | 2015-12-03 |
| EP2780448A1 (en) | 2014-09-24 |
| US20180010100A1 (en) | 2018-01-11 |
| WO2013074650A1 (en) | 2013-05-23 |
| IL232621B (en) | 2019-10-31 |
| CN106479990B (zh) | 2020-09-18 |
| US11713451B2 (en) | 2023-08-01 |
| SG11201402401TA (en) | 2014-06-27 |
| US20160319247A1 (en) | 2016-11-03 |
| US10851351B2 (en) | 2020-12-01 |
| US20190177702A1 (en) | 2019-06-13 |
| CN106479990A (zh) | 2017-03-08 |
| US9139819B2 (en) | 2015-09-22 |
| CN104053771B (zh) | 2016-11-09 |
| US10253303B2 (en) | 2019-04-09 |
| US9422531B2 (en) | 2016-08-23 |
| IL232621A0 (en) | 2014-06-30 |
| US20240018489A1 (en) | 2024-01-18 |
| US10100287B2 (en) | 2018-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN04470A (enrdf_load_stackoverflow) | ||
| ZA201502433B (en) | Methods of host cell modification | |
| IL231171A0 (en) | RNA-derived t cells for cancer treatment | |
| AP3964A (en) | Methods of processing lignocellulosic biomass | |
| IN2014CN04586A (enrdf_load_stackoverflow) | ||
| IL237898A0 (en) | Systems for cell culture in 3D, and methods for their preparation and uses | |
| MX337985B (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| MX337919B (es) | Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| PL3070170T3 (pl) | Fermentacja CO<sub>2</sub> z zastosowaniem potencjału elektrycznego | |
| MX337913B (es) | Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos. | |
| MX2014004598A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| SG10201510009YA (en) | Methods of metabolic targeting cancer cells using chemo- and immunotherapy for treating cancer | |
| MX2014004539A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| ZA201504408B (en) | Solution formulations of engineered anti-il-23p19 antibodies | |
| SG10201706813WA (en) | Culture medium for proliferating stem cell, which contains sulfated compound | |
| MX2014001594A (es) | Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican. | |
| WO2013011062A3 (en) | Antagonistic antibodies against oscar | |
| ZA201403104B (en) | Process for the preparation of higher alcohols | |
| HK1210436A1 (en) | Novel cell compositions and methods | |
| HK40119617A (en) | Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue | |
| HK40022222B (en) | Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue | |
| MY166897A (en) | Stable compositions and methods for preparing the same | |
| IL229242B (en) | Allogeneic cell vaccine for cancer | |
| AU2012905250A0 (en) | Uses of Bacopa monnieri extract | |
| GB201219906D0 (en) | Matrix binders, uses & methods of manufacture |